The importance of Biomarkers in drug discovery and development is constantly growing. In drug development, Biomarkers are used to confirm mechanism of action, monitor disease progress and assess drug efficacy and safety.
In addition, Biomarkers are deployed for pharmacokinetic / pharmacodynamic (PK / PD) modeling. Because of the central role throughout all phases of drug development, Biomarker assessment requires robust and sensitive assays with high accuracy and precision. IBR Inc. has longstanding experience in Biomarker assessment including assay development and validation under GLP and GCP quality standards in accordance with regulations (EMA, FDA, ICH).